Oxygen Therapy for Patients Presenting with an SpO₂ of 88 %

Initial Assessment & Risk Stratification

• Determine hypercapnia risk before setting oxygen targets – patients without risk factors should aim for an SpO₂ of 94‑98 %; those with risk factors (e.g., COPD, morbid obesity, neuromuscular disease) should aim for 88‑92 % [BTS] [1, 2, 3, 4].

• Identify hypercapnia‑risk conditions – COPD, morbid obesity, cystic fibrosis, chest‑wall deformities, neuromuscular disorders, or fixed airflow obstruction with bronchiectasis place patients in the at‑risk group [BTS] [5, 4].

• Treat suspected COPD as at‑risk when the patient is > 50 years, a long‑term smoker, and has chronic breathlessness on minor exertion, until proven otherwise [BTS] [3, 4].

Oxygen Delivery Devices & Initial Targets

• Patients not at risk of hypercapnia – start with nasal cannula 2‑6 L/min (preferred) or a simple face mask 5‑10 L/min; if SpO₂ remains < 85 % despite this, immediately switch to a reservoir mask 15 L/min [BTS] [1].

• Patients at risk of hypercapnia – use a 24 % Venturi mask 2‑3 L/min, a 28 % Venturi mask 4 L/min, or nasal cannula 1‑2 L/min to keep SpO₂ 88‑92 % [BTS] [3, 6].

• Escalation requirement – senior medical staff must assess the patient before escalating to a reservoir mask 15 L/min [BTS] [2].

Immediate Monitoring Requirements

• Arterial blood gases should be obtained within 30‑60 minutes of initiating oxygen therapy [BTS] [1, 2].

• Respiratory and heart rates are more sensitive early indicators of hypoxaemia than visible cyanosis and must be recorded promptly [BTS] [1, 2].

• High‑priority triage is indicated when any hypercapnic‑risk factor is present [BTS] [3, 4].

Blood‑Gas‑Guided Oxygen Adjustment

For all patterns, repeat arterial blood gases after 30‑60 minutes to detect trends [BTS] [7, 6].

Safe Oxygen Weaning & Device Considerations

• Never abruptly stop oxygen in suspected hypercapnic patients; taper gradually using a 24 % or 28 % Venturi mask or nasal cannula 1‑2 L/min to keep SpO₂ 88‑92 % [BTS] [6].

• Rapid cessation can cause a sudden fall in saturation below baseline [BTS] [6].

• High respiratory rates (>30 breaths/min) – increase flow through Venturi masks above the minimum setting (does not change FiO₂ but meets inspiratory demand) [BTS] [3, 6].

Investigation & Management of Underlying Causes

Evidence Base

The British Thoracic Society 2017 guideline synthesises the highest‑quality evidence available for acute oxygen therapy and forms the backbone of all recommendations above [BTS] [1, 2, 9, 3, 4, 6, 5, 7, 8, 10].

Oxygen Therapy Escalation When SpO₂ Is 90 % on a Face Mask

Target Saturation Goals

• For patients without hypercapnic risk factors, the recommended peripheral oxygen saturation (SpO₂) target is 94 %–98 %; a value of 90 % is considered inadequate. [11][12]
• For patients with hypercapnic risk factors (e.g., COPD, morbid obesity, neuromuscular disease, chest‑wall deformities), the target SpO₂ range is 88 %–92 %. (guideline context, not a cited fact)

Escalation Recommendations (British Thoracic Society)

• The British Thoracic Society states that when medium‑concentration oxygen delivery (simple face mask or nasal cannula) fails to achieve the desired saturation, clinicians must escalate to a reservoir (non‑rebreather) mask at 15 L/min and obtain senior medical input; switching to a lower‑flow device is contraindicated. [11][12]
• In a patient on a face mask with SpO₂ = 90 % and no hypercapnic risk, the immediate action is to replace the face mask with a reservoir mask at 15 L/min to reach the 94 %–98 % target. [11][12]
• An urgent senior medical review should be requested whenever escalation is required. 12

Contraindicated De‑escalation

• Do not downgrade oxygen delivery (e.g., switch from face mask to nasal cannula) solely because SpO₂ appears “stable” at 90 %; this level indicates insufficient oxygenation and the need for escalation, not weaning. 11
• Comfort‑driven device changes should be deferred until the patient consistently maintains ≥94 % SpO₂ (for non‑hypercapnic patients). 11

Preferred Initial Device and Weaning Considerations

• Nasal cannulae are the preferred initial oxygen delivery device for patients presenting with mild‑to‑moderate hypoxemia who can achieve 94 %–98 % SpO₂ on low‑to‑medium flow (1–6 L/min). 11
• Nasal cannulae are also appropriate for stable patients being weaned from higher‑flow oxygen, provided they maintain target saturations. (guideline context, not a cited fact)
• In the presented scenario—persistent hypoxemia on a face mask with SpO₂ = 90 %—the patient requires escalation rather than device substitution. [11][12]

Standardized Oxygen Therapy and Monitoring Guidelines

Equipment and Infrastructure

• The respiratory therapy unit must keep a standardized inventory of equipment—including piped oxygen supply with backup cylinders secured on trolleys, nasal cannulae (preferred for medium‑concentration oxygen), simple face masks (5–10 L/min), Venturi masks (24 % at 2–3 L/min and 28 % at 4 L/min), reservoir (non‑rebreather) masks (15 L/min), and pediatric flow meters for precise low‑flow delivery—to ensure safe, evidence‑based care. 13
• Monitoring equipment should include pulse oximeters for continuous and spot‑check monitoring, arterial blood‑gas (ABG) analyzers that can provide results within 30–60 minutes, and systems for respiratory‑rate and vital‑sign monitoring. [14][15]
• High‑risk aerosol‑generating procedures must be performed with dedicated equipment and appropriate personal protective equipment (PPE). 14

Staffing and Training

• Respiratory therapists must be credentialed and trained in high‑risk procedures (including aerosol‑generating procedures and non‑invasive ventilation initiation) before performing them independently. 14
• Training programs should cover safe oxygen‑titration protocols, NIV initiation and monitoring, and aerosol‑generating procedure safety. [15][14]
• Protocols should emphasize bedside performance of procedures whenever possible to minimise patient transport risks. 14

Oxygen Saturation Targets

• For patients without hypercapnia risk (e.g., most acute medical conditions, postoperative patients, trauma, pneumonia), aim for a peripheral SpO₂ of 94 %–98 %. 13
• For patients with hypercapnia risk (e.g., COPD, morbid obesity, cystic fibrosis, chest‑wall deformities, neuromuscular disease, bronchiectasis with fixed obstruction), aim for a peripheral SpO₂ of 88 %–92 %. 13

Device Selection

• Non‑hypercapnic patients – If SpO₂ ≥ 85 % start nasal cannula 2–6 L/min (preferred) or a simple face mask 5–10 L/min; if SpO₂ < 85 % apply a reservoir mask at 15 L/min. Nasal cannulae are preferred for comfort, meal tolerance, and cost savings. 13
• Hypercapnic‑risk patients – Use a 24 % Venturi mask at 2–3 L/min, a 28 % Venturi mask at 4 L/min, or nasal cannula 1–2 L/min. Escalation to a reservoir mask requires senior approval. 15

Monitoring After Oxygen Initiation

• Measure SpO₂ five minutes after any oxygen start or flow adjustment.
• In hypercapnic‑risk patients, obtain an ABG within 30–60 minutes of starting oxygen and repeat the ABG 30–60 minutes after any flow change; repeat even if the initial PCO₂ was normal because hypercapnia can develop during admission. 15

Blood‑Gas‑Guided Oxygen Adjustment (Hypercapnic‑Risk Patients)

If hypercapnia is suspected due to excessive oxygen, step down to a 24 % or 28 % Venturi mask or to nasal cannula 1–2 L/min—*never abruptly stop oxygen**, as this can cause life‑threatening rebound hypoxemia. 15

Escalation Protocol

• Escalate oxygen delivery immediately when SpO₂ remains < 94 % (or < 88 % in hypercapnic‑risk patients) despite appropriate device and flow.
• For hypercapnic‑risk patients, senior medical assessment is required before moving to a reservoir mask; consider NIV if oxygen requirements increase despite controlled delivery. 15
• Urgent clinical review is indicated if the National Early Warning Score (NEWS) reaches ≥ 7 or if respiratory acidosis develops (pH < 7.35, PCO₂ > 6 kPa). 15

Weaning Protocol

• Non‑hypercapnic patients – Reduce flow incrementally once SpO₂ is consistently ≥ 94 %; step down to nasal cannula 2 L/min before discontinuation; re‑measure SpO₂ at 5 minutes and 1 hour after stopping oxygen.
• Hypercapnic‑risk patients – Switch from Venturi mask to nasal cannula once stable; taper gradually (never abrupt); repeat ABG after each reduction. 15

Special Clinical Scenarios

COPD Exacerbations

• Initiate controlled oxygen with a 24 % Venturi mask 2–3 L/min or nasal cannula 1–2 L/min, targeting SpO₂ 88 %–92 %. Obtain an ABG within 30–60 minutes. If PCO₂ > 6 kPa and pH < 7.35 persist > 30 minutes after standard therapy, start NIV. Avoid PaO₂ > 10 kPa to reduce the risk of respiratory acidosis. 15

Neuromuscular Disease and Respiratory Failure

• Begin with a target SpO₂ 88 %–92%; obtain ABG to determine NIV need; monitor with serial ABG and regular spirometry (forced vital capacity). These patients have a high risk of mortality and require early discussion of ventilatory wishes. 15

Safety Checks and PPE for Aerosol‑Generating Procedures

• Verify oxygen connections, flow rates, and pulse‑oximeter probe placement before attributing desaturation to pathology; ensure cylinders are secured, checked for leaks, and stored away from direct sunlight, with a green “compressed gas” warning triangle displayed at the unit entrance. 13
• Aerosol‑generating procedures must be performed with enhanced PPE and according to detailed protocols that define the procedure, qualified personnel, site, equipment, and safe technique; training must be completed before staff perform these procedures, and they should be performed at bedside whenever possible. 14

Documentation, Training, and Continuous Quality Improvement

• Conduct regular training and competency assessments for all respiratory‑therapy staff. 14
• Use Delphi or consensus processes to update oxygen‑therapy protocols as new evidence emerges, and provide ongoing education and simulation training for staff. 14
• Maintain emergency‑preparedness protocols that include PPE stockpiles, criteria for cancelling elective procedures, and coordination with ICU, emergency, and ward units. 14

Venturi Mask Settings for CO₂ Washout in Patients at Risk of Hypercapnia

Flow Rate Recommendations Based on Respiratory Rate

• In patients with a respiratory rate < 30 breaths/min, a 24 % Venturi mask set at 2–3 L/min provides a total gas flow of approximately 51 L/min, and a 28 % Venturi mask set at 4 L/min provides about 44 L/min of total flow. 16
• For patients whose respiratory rate > 30 breaths/min, the oxygen flow should be increased by 50 % above the manufacturer‑specified minimum to maintain adequate total gas flow and prevent CO₂ rebreathing while keeping the prescribed FiO₂ unchanged. [17][18]
• Raising the oxygen flow into a Venturi mask raises the total gas flow but does not alter the delivered FiO₂ concentration. [17][18]

Rationale for Adequate Flow (CO₂ Washout)

• The total gas flow generated by the Venturi system must exceed the patient’s peak inspiratory flow to avoid entrainment of room air, which would dilute the intended FiO₂. 19
• Sufficient flow also prevents CO₂ rebreathing from the mask dead space. [17][18]
• Simple face masks delivering < 5 L/min are associated with CO₂ rebreathing and increased inspiratory resistance, making Venturi masks the preferred device for controlled oxygen delivery in this population. [17][18]

Target Oxygen Saturations

• Hypercapnic‑risk patients (e.g., COPD, obesity‑hypoventilation, neuromuscular disease) should be titrated to an SpO₂ range of 88–92 %. [19][17]18
  
  • Initial settings: 24 % Venturi mask at 2–3 L/min or 28 % Venturi mask at 4 L/min. [19][17]
  • An alternative is a nasal cannula delivering 1–2 L/min, which can achieve a comparable SpO₂ range. [19][17]18
• Non‑hypercapnic patients should be targeted to an SpO₂ range of 94–98 %. [19][20]
  
  • First‑line devices: nasal cannula 2–6 L/min or simple face mask 5–10 L/min. [17][18]
  • If SpO₂ remains < 85 % despite these measures, escalation to a reservoir mask at 15 L/min is recommended. [17][20]

Factors That Can Reduce Delivered FiO₂

• When a patient’s inspiratory flow exceeds the total flow provided by the Venturi mask, the effective FiO₂ may fall below the nominal setting. 19
• Poor mask fit that allows room‑air entrainment also diminishes the delivered FiO₂. 16

Escalation Triggers Requiring Re‑assessment

• Persistent respiratory rate > 30 breaths/min after the recommended 50 % flow increase. [17][18]
• Failure to achieve the target SpO₂ despite appropriate device selection and flow adjustments.

Contraindications for High‑Flow Nasal Cannula (HFNC)

• HFNC should not be used in hypercapnic‑risk patients unless a non‑invasive ventilation (NIV) backup is available, because it may precipitate CO₂ retention. 18